Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ASO Visual Abstract: Long-Term Outcomes of Patients with Gastric Cancer and Positive Peritoneal Cytology.

Annals of surgical oncology·2026
Same author

Long-Term Outcomes of Patients with Gastric Cancer and Positive Peritoneal Cytology.

Annals of surgical oncology·2026
Same author

Genomic Signatures of Gastric Adenocarcinoma By Tumor Location-Modified Laurén Classification: Highlighting the Molecular Heterogeneity of Mixed-Type Tumors.

The American journal of surgical pathology·2025
Same author

Interpretable artificial intelligence to optimise use of imatinib after resection in patients with localised gastrointestinal stromal tumours: an observational cohort study.

The Lancet. Oncology·2024
Same author

Blue Ribbon Committee I Review: Findings and Impact.

Annals of surgery·2024
Same author

Patient metabolic profile defined by liver and muscle <sup>18</sup>F-FDG PET avidity is independently associated with overall survival in gastric cancer.

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·2024

Related Experiment Video

Updated: May 4, 2026

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

8.5K

Lessons learned from the study of soft tissue sarcoma.

Murray F Brennan1

  • 1Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.

International Journal of Surgery (London, England)
|January 2, 2014
PubMed
Summary

This 30-year study of soft tissue sarcoma highlights site-specific outcomes and histology

Area of Science:

  • Oncology
  • Surgical Pathology
  • Cancer Research

Background:

  • Soft tissue sarcoma is a rare and heterogeneous cancer.
  • A prospective database of over 10,000 patients treated since 1982 provides extensive data.
  • Understanding sarcoma biology and patient outcomes is crucial for effective treatment.

Purpose of the Study:

  • To analyze 30 years of prospective data on soft tissue sarcoma patients.
  • To identify key determinants of patient outcomes, including demographics, site, and histology.
  • To evaluate the efficacy of different treatment modalities and risk factors.

Main Methods:

  • Prospective data collection and weekly review of a surgical sarcoma patient database.
  • Analysis of patient demographics, tumor site, histology, treatment, and outcomes.
Keywords:
SarcomaSoft tissue

More Related Videos

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

13.7K
The In ovo CAM-assay as a Xenograft Model for Sarcoma
12:44

The In ovo CAM-assay as a Xenograft Model for Sarcoma

Published on: July 17, 2013

25.2K

Related Experiment Videos

Last Updated: May 4, 2026

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

8.5K
Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

13.7K
The In ovo CAM-assay as a Xenograft Model for Sarcoma
12:44

The In ovo CAM-assay as a Xenograft Model for Sarcoma

Published on: July 17, 2013

25.2K
  • Correlation of clinical factors with disease recurrence, survival, and treatment response.

    • Main Results:

    • Tumor site significantly impacts outcomes; retroperitoneal sarcomas (especially liposarcoma) show high local recurrence and mortality.
    • Limb preservation is as effective as amputation for survival in extremity sarcomas.
    • Radiation therapy can reduce local recurrence but requires balancing against side effects; chemotherapy shows limited benefit.

    Conclusions:

    • Soft tissue sarcoma outcomes are highly dependent on tumor histology and location.
    • Databases are invaluable for understanding sarcoma biology, incidence, and patient outcomes.
    • Limb preservation and radiation therapy are important treatment considerations, while chemotherapy efficacy remains limited.